Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210360040> ?p ?o ?g. }
- W4210360040 endingPage "1075" @default.
- W4210360040 startingPage "1065" @default.
- W4210360040 abstract "People with atrial fibrillation (AF) frequently live with frailty, which increases the risk of mortality and stroke. This study reports the association between oral anticoagulation (OAC) and outcomes for people with frailty, and whether there is overall net benefit from treatment in people with AF.Retrospective open cohort electronic records study. Frailty was identified using the electronic frailty index. Primary care electronic health records of 89 996 adults with AF and CHA2DS2-Vasc score of ≥2 were linked with secondary care and mortality data in the Clinical Practice Research Database (CPRD) from 1 January 1998 to 30 November 2018. The primary outcome was a composite of death, stroke, systemic embolism, or major bleeding. Secondary outcomes were stroke, major bleeding, all-cause mortality, transient ischaemic attack, and falls. Of 89 996 participants, 71 256 (79.2%) were living with frailty. The prescription of OAC increased with degree of frailty. For patients not prescribed OAC, rates of the primary outcome increased alongside frailty category. Prescription of OAC was associated with a reduction in the primary outcome for each frailty category [adjusted hazard ratio, 95% confidence interval, no OAC as reference; fit: vitamin K antagonist (VKA) 0.69, 0.64-0.75, direct oral anticoagulant (DOAC) 0.42, 0.33-0.53; mild frailty: VKA 0.52, 0.50-0.54, DOAC 0.57, 0.52-0.63; moderate: VKA 0.54, 0.52-0.56, DOAC 0.57, 0.52-0.63; severe: VKA 0.48, 0.45-0.51, DOAC 0.58, 0.52-0.65], with cumulative incidence function effects greater for DOAC than VKA.Frailty among people with AF is common. The OAC was associated with a reduction in the primary endpoint across all degrees of frailty." @default.
- W4210360040 created "2022-02-08" @default.
- W4210360040 creator A5004462218 @default.
- W4210360040 creator A5006205778 @default.
- W4210360040 creator A5014134771 @default.
- W4210360040 creator A5017292057 @default.
- W4210360040 creator A5054578676 @default.
- W4210360040 creator A5072133238 @default.
- W4210360040 creator A5085211820 @default.
- W4210360040 date "2022-03-04" @default.
- W4210360040 modified "2023-10-14" @default.
- W4210360040 title "Impact of oral anticoagulation on the association between frailty and clinical outcomes in people with atrial fibrillation: nationwide primary care records on treatment analysis" @default.
- W4210360040 cites W1508825876 @default.
- W4210360040 cites W2119852447 @default.
- W4210360040 cites W2146417320 @default.
- W4210360040 cites W2291720716 @default.
- W4210360040 cites W2757170813 @default.
- W4210360040 cites W2788585678 @default.
- W4210360040 cites W2901264117 @default.
- W4210360040 cites W2921813015 @default.
- W4210360040 cites W2995889897 @default.
- W4210360040 cites W3006589096 @default.
- W4210360040 cites W3016133011 @default.
- W4210360040 cites W3048941456 @default.
- W4210360040 cites W3082188176 @default.
- W4210360040 cites W3108889960 @default.
- W4210360040 cites W3112298818 @default.
- W4210360040 cites W3150331195 @default.
- W4210360040 cites W3184824800 @default.
- W4210360040 cites W4206007300 @default.
- W4210360040 cites W4210440929 @default.
- W4210360040 doi "https://doi.org/10.1093/europace/euac022" @default.
- W4210360040 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35244709" @default.
- W4210360040 hasPublicationYear "2022" @default.
- W4210360040 type Work @default.
- W4210360040 citedByCount "7" @default.
- W4210360040 countsByYear W42103600402022 @default.
- W4210360040 countsByYear W42103600402023 @default.
- W4210360040 crossrefType "journal-article" @default.
- W4210360040 hasAuthorship W4210360040A5004462218 @default.
- W4210360040 hasAuthorship W4210360040A5006205778 @default.
- W4210360040 hasAuthorship W4210360040A5014134771 @default.
- W4210360040 hasAuthorship W4210360040A5017292057 @default.
- W4210360040 hasAuthorship W4210360040A5054578676 @default.
- W4210360040 hasAuthorship W4210360040A5072133238 @default.
- W4210360040 hasAuthorship W4210360040A5085211820 @default.
- W4210360040 hasBestOaLocation W42103600401 @default.
- W4210360040 hasConcept C126322002 @default.
- W4210360040 hasConcept C127413603 @default.
- W4210360040 hasConcept C167135981 @default.
- W4210360040 hasConcept C187212893 @default.
- W4210360040 hasConcept C194828623 @default.
- W4210360040 hasConcept C201903717 @default.
- W4210360040 hasConcept C207103383 @default.
- W4210360040 hasConcept C2426938 @default.
- W4210360040 hasConcept C2776301958 @default.
- W4210360040 hasConcept C2776704044 @default.
- W4210360040 hasConcept C2779161974 @default.
- W4210360040 hasConcept C2780645631 @default.
- W4210360040 hasConcept C44249647 @default.
- W4210360040 hasConcept C50382708 @default.
- W4210360040 hasConcept C71924100 @default.
- W4210360040 hasConcept C78519656 @default.
- W4210360040 hasConcept C98274493 @default.
- W4210360040 hasConceptScore W4210360040C126322002 @default.
- W4210360040 hasConceptScore W4210360040C127413603 @default.
- W4210360040 hasConceptScore W4210360040C167135981 @default.
- W4210360040 hasConceptScore W4210360040C187212893 @default.
- W4210360040 hasConceptScore W4210360040C194828623 @default.
- W4210360040 hasConceptScore W4210360040C201903717 @default.
- W4210360040 hasConceptScore W4210360040C207103383 @default.
- W4210360040 hasConceptScore W4210360040C2426938 @default.
- W4210360040 hasConceptScore W4210360040C2776301958 @default.
- W4210360040 hasConceptScore W4210360040C2776704044 @default.
- W4210360040 hasConceptScore W4210360040C2779161974 @default.
- W4210360040 hasConceptScore W4210360040C2780645631 @default.
- W4210360040 hasConceptScore W4210360040C44249647 @default.
- W4210360040 hasConceptScore W4210360040C50382708 @default.
- W4210360040 hasConceptScore W4210360040C71924100 @default.
- W4210360040 hasConceptScore W4210360040C78519656 @default.
- W4210360040 hasConceptScore W4210360040C98274493 @default.
- W4210360040 hasFunder F4320306262 @default.
- W4210360040 hasFunder F4320309229 @default.
- W4210360040 hasFunder F4320314731 @default.
- W4210360040 hasFunder F4320319990 @default.
- W4210360040 hasIssue "7" @default.
- W4210360040 hasLocation W42103600401 @default.
- W4210360040 hasLocation W42103600402 @default.
- W4210360040 hasLocation W42103600403 @default.
- W4210360040 hasLocation W42103600404 @default.
- W4210360040 hasLocation W42103600405 @default.
- W4210360040 hasOpenAccess W4210360040 @default.
- W4210360040 hasPrimaryLocation W42103600401 @default.
- W4210360040 hasRelatedWork W2026094606 @default.
- W4210360040 hasRelatedWork W2071306276 @default.
- W4210360040 hasRelatedWork W2174666533 @default.
- W4210360040 hasRelatedWork W2611840721 @default.
- W4210360040 hasRelatedWork W2738554408 @default.